Variant · Snv
C5 NM_001735.3(C5):c.1418A>G (p.His473Arg)
CI-VAR-00191374Explore in graph →p.His473ArgNM_001735.3:c.1418A>GClinVar 1135683 rs78640581
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1135683 | Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Eculizumab, poor response to; Complement component 5 deficiency; Gastric cancer; Uterine corpus endometrial carcinoma; Ovarian serous cystadenocarcinoma; Malignant tumor of urinary bladder; Familial cancer of breast | germline | 3 | Dec 22, 2025 | clinvar |